Published: 2018-10-22

Articles

A Practical Methodology for Disaggregating the Drivers of Drug Costs Using Administrative Data

Elena R. Lungu, Orlando J. Manti, Mitchell A.H. Levine, Douglas A. Clark, Tanya M. Potashnik, Carol I. McKinley
Abstract 11 | PDF Downloads 15
PDF

LACK OF HEALTH-RELATED QUALITY OF LIFE AND PATIENT-CENTRED OUTCOME MEASURES IN RANDOMIZED CONTROLLED TRIALS CONDUCTED FOR DIABETES PHARMACOTHERAPY: SGLT-2 RECEPTOR INHIBITORS AS AN EXAMPLE

Pendar Farahani
Abstract 19 | PDF Downloads 17
PDF

Use of Continuous Exposure Variables When Examining Dose-Dependent Pharmacological Effects Application to the Association Between Exposure to Higher Statin Doses and the Incidence of Diabetes

Jason R Guertin, Elham Rahme, Jacques LeLorier
Abstract 12 | PDF Downloads 12
PDF

Caring for Patients with Prenatal Alcohol Exposure: A Needs Assessment

Vincent C. Smith, Phillip Matthias, Yasmin N. Senturias, Renee M. Turchi, Janet F. Williams
Abstract 12 | PDF Downloads 18
PDF

Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic Fibrosis

Isabelle Goyer, Massimiliano Iseppon, Céline Thibault, Rachid Abaji, Maja Krajinovic, Julie Autmizguine
Abstract 21 | PDF Downloads 19
PDF

Adoption of the Nova Scotia (Canada) Community Pharmacy Medication Management Program, 1-Year Post-Initiation

Heidi J. Deal, Charmaine A. Cooke, Ethel M. Langille Ingram, Ingrid S. Sketris
Abstract 24 | PDF Downloads 12
PDF

Retrospective Analysis of Emerging Drugs Use in a Quebec Women's and Children's University Hospital and Perspectives for Safe and Optimal Drug Use

Jennifer Corny, Elaine Pelletier, Denis Lebel, Jean-François Bussières
Abstract 10 | PDF Downloads 11
PDF